Scientific news

Rockefeller Institute: Legal marijuana linked to opioid-use declines amid drug crisis

Some states allowing medical marijuana and recreational pot saw declines in opioid prescribing as authorities pushed urgent efforts to combat the historic American drug crisis.

Medical cannabis research at the University of Alberta receives $300k in funding

This research will span over roughly four years and will analyze how patients who use medical cannabis and patients who don’t interact differently with the health care system.

Opioids and pot: inside the fight for real research

Two new studies show a correlation between medical marijuana and lowered rates of opioid abuse – but what is it about weed that seems to help?

Cannabis versus cancer

We know weed can mitigate the side effects of the disease and its treatments, but it might also fight malignancies directly.

Can marijuana treat autism? These clinical trials aim to find out

A growing number of clinical trials are looking into whether compounds in marijuana can be used to treat some of the symptoms of autism.

UC San Diego study to examine cannabis plant extract's effect on severe autism

San Diego researchers are looking into the potential of using cannabidiol as a treatment for severe autism.

Could hemp help to beat ovarian cancer?

Although hemp has fallen out of favor over the years, some scientists believe that a certain strain could help in the battle against ovarian cancer.

Scientific guidelines for using cannabis to treat stress, anxiety and depression

In a first-of-a-kind study, Washington State University scientists examined how peoples' self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home.

How can medical marijuana benefit older adults?

Managing symptoms such as pain, nausea, and psychiatric illness can be challenging as people age. A new review highlights what's currently known about the indications and risks of medical marijuana use for older adults.

Breaking new ground: Zelda Therapeutics to test effects of cannabis on diabetic dementia

Bio-pharmaceutical company Zelda Therapeutics (ASX: ZLD) has partnered with Curtin University to test the effects of cannabis on cognitive decline, one of the most debilitating symptoms of diabetes.